These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 11174632)

  • 41. Azithromycin-induced torsade de pointes.
    Huang BH; Wu CH; Hsia CP; Yin Chen C
    Pacing Clin Electrophysiol; 2007 Dec; 30(12):1579-82. PubMed ID: 18070319
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The morphology of the QT interval predicts torsade de pointes during acquired bradyarrhythmias.
    Topilski I; Rogowski O; Rosso R; Justo D; Copperman Y; Glikson M; Belhassen B; Hochenberg M; Viskin S
    J Am Coll Cardiol; 2007 Jan; 49(3):320-8. PubMed ID: 17239713
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Acute alcoholic hepatitis complicated by cardiac arrhythmia. Alcohol, hepatitis, hypomagnesemia, torsades de pointes, corticotherapy].
    Morgado MJ; Marques A; Areias E; Moura MC
    Acta Med Port; 1994 Mar; 7(3):171-4. PubMed ID: 8209703
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Monotherapy versus combination therapy with class III antiarrhythmic agents to attenuate transmural dispersion of repolarization: a potential risk factor for torsade de pointes.
    Shah SA; Kluger J; White CM
    Pharmacotherapy; 2007 Sep; 27(9):1297-305. PubMed ID: 17723083
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Pheochromocytoma of the left retroperitoneal paraganglion associated with torsade de pointes: a case report].
    Kihara H; Terai H; Kihara Y; Kihara T; Takahashi H; Kosuda A; Shimomoto M; Fukunishi M; Tanaka T
    J Cardiol; 1997 Jul; 30(1):37-44. PubMed ID: 9253694
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Torsade de pointes--a rare presentation of primary hyperaldosteronism.
    Kornelius E; Chen KS; Yang YS; Huang CN
    Am J Emerg Med; 2012 Jan; 30(1):257.e5-7. PubMed ID: 21159461
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Torsades de pointes in congenital long QT syndrome following low-dose orphenadrine.
    Luzza F; Raffa S; Saporito F; Oreto G
    Int J Clin Pract; 2006 May; 60(5):606-8. PubMed ID: 16700864
    [TBL] [Abstract][Full Text] [Related]  

  • 48. "Torsade de pointes" during amiodarone infusion in a cirrhotic woman with a prolonged QT interval.
    Di Micoli A; Zambruni A; Bracci E; Benazzi B; Zappoli P; Berzigotti A; Zoli M; Bernardi M; Trevisani F
    Dig Liver Dis; 2009 Jul; 41(7):535-8. PubMed ID: 18294935
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Congenital long QT syndrome].
    Haverkamp W
    Herz; 2007 May; 32(3):201-5. PubMed ID: 17497252
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Torsade de pointes.
    Bubien R
    Am J Nurs; 1999 Sep; 99(9):36-7. PubMed ID: 10489578
    [No Abstract]   [Full Text] [Related]  

  • 51. QT interval prolongation and ventricular fibrillation in childhood end-stage renal disease.
    Kim GB; Cho HY; Kwon BS; Bae EJ; Noh CI; Choi JY; Yun YS; Choi Y; Ha JW
    Int J Cardiol; 2008 Jul; 127(3):e126-8. PubMed ID: 17714808
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A case series of drug-induced long QT syndrome and Torsade de Pointes.
    Tong KL; Lau YS; Teo WS
    Singapore Med J; 2001 Dec; 42(12):566-70. PubMed ID: 11989578
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel therapeutics for treatment of long-QT syndrome and torsade de pointes.
    Khan IA; Gowda RM
    Int J Cardiol; 2004 May; 95(1):1-6. PubMed ID: 15159030
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Images in cardiovascular medicine. Torsade de pointes in a patient with Wolff-Parkinson-White syndrome.
    Kobza R; Kottkamp H; Hindricks G
    Circulation; 2005 Apr; 111(13):e173-4. PubMed ID: 15811862
    [No Abstract]   [Full Text] [Related]  

  • 55. Chronic methadone therapy complicated by torsades de pointes: a case report.
    Pimentel L; Mayo D
    J Emerg Med; 2008 Apr; 34(3):287-90. PubMed ID: 18022786
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Short coupled variant of "torsades de pointes" and sudden death].
    Hentati M; Krichene S; Kechida Z; Chahbani I; Hached L; Grati Z; Charfeddine H; Kammoun S
    Tunis Med; 2004 Jun; 82(6):542-5. PubMed ID: 15517954
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prolonged QT interval and torsades de pointes associated with atazanavir therapy.
    Ly T; Ruiz ME
    Clin Infect Dis; 2007 Mar; 44(6):e67-8. PubMed ID: 17304444
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-QT syndrome and torsades de pointes in a patient with Takotsubo cardiomyopathy: an unusual case.
    Mahida S; Dalageorgou C; Behr ER
    Europace; 2009 Mar; 11(3):376-8. PubMed ID: 19095686
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Female preponderance in ibutilide-induced torsade de pointes.
    Gowda RM; Khan IA; Punukollu G; Vasavada BC; Sacchi TJ; Wilbur SL
    Int J Cardiol; 2004 Jun; 95(2-3):219-22. PubMed ID: 15193823
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Torsades de pointes and self-terminating ventricular fibrillation in a prescription methadone user.
    Atkinson D; Dunne A; Parker M
    Anaesthesia; 2007 Sep; 62(9):952-5. PubMed ID: 17697226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.